Results 291 to 300 of about 553,087 (356)

Precise Control of Drug Release in Machine Learning‐Designed Antibody‐Eluting Implants for Postoperative Scarring Inhibition in Glaucoma

Advanced Healthcare Materials, EarlyView.
We developed a micro‐sized, biocompatible implant for postoperative sustained delivery of anti‐fibrotic antibodies in glaucoma surgery. Machine learning‐guided optimization of polymer composition, implant geometry, and porosity enabled precise control of drug release.
Mengqi Qin, Wenbing Jiang, Kai Xin Thong, Zeynep Ulker, Brihitejas Patel, Cynthia Yu‐Wai‐Man   +5 more
wiley   +1 more source

Baseline intact fibroblast growth factor 23 and risk of kidney disease progression in the Indian Chronic Kidney Disease cohort: a prospective multicenter study. [PDF]

Front Med (Lausanne)
Kamboj K, Yadav AK, Rastogi A, Ghosh A, Sharma S, Jain L, Kumar V, Jha V, Indian Chronic Kidney Disease Study Network.   +8 more
europepmc   +1 more source

Efficacy of recombinant bovine basic fibroblast growth factor gel combined with compound polymyxin B ointment on wound healing after fistulotomy. [PDF]

Medicine (Baltimore)
Long Q, Li Y.
europepmc   +1 more source

Fibroblast Growth Factor 8 Suppresses Neurotoxic Astrocytes and Alleviates Neuropathic Pain via Spinal FGFR3 Signaling. [PDF]

Neurosci Bull
Liu H, Yi L, Li G, Wang K, Wang H, Zhang Y, Liu B.   +6 more
europepmc   +1 more source

Serum fibroblast growth factor 23 and kidney injury molecule-1 in the prediction of acute kidney injury in critically-ill patients. [PDF]

Ren Fail
Zhang L, Wang L, Yan B, Pei X, Wang N, Yan L, Cao H, Shao F.   +7 more
europepmc   +1 more source

Correction to "Enhanced Growth of Bone Marrow-Derived Mesenchymal Stem Cells on the Microcarriers Tethered With Engineered Basic Fibroblast Growth Factor". [PDF]

Biotechnol J
europepmc   +1 more source

Inter-laboratory comparison of a serum fibroblast growth factor receptor 3 (FGFR3) antibody test in sensory neuropathies. [PDF]

Front Immunol
Appeltshauser L, Moritz CP, Reinhardt L, Kreß L, Üçeyler N, Lassablière F, Barcic A, Seefried S, Sommer C, Tholance Y, Antoine JC, Camdessanché JP, Doppler K.   +12 more
europepmc   +1 more source

Molecular Mechanisms and Clinical Implications of <i>Fibroblast Growth Factor Receptor 2</i> Signaling in Gastrointestinal Stromal Tumors. [PDF]

Curr Issues Mol Biol
Hong Y, Wang X, Shou C, Liu X.
europepmc   +1 more source